Mechanisms responsible for the hypocholesterolaemic effect of regular consumption of probiotics
Tóm tắt
CVD affect a large proportion of the world’s population, with dyslipidaemia as the major risk factor. The regular consumption of both probiotic bacteria and yeast has been associated with improvement in the serum lipid profile. Thus, the present review aims to describe and discuss the potential mechanisms responsible for the hypocholesterolaemic effect of regular consumption of probiotic bacteria and yeast. Regarding the hypocholesterolaemic effect of probiotic bacteria, the potential mechanisms responsible include: deconjugation of bile salts; modulation of lipid metabolism; and decreased absorption of intestinal cholesterol through co-precipitation of intestinal cholesterol with the deconjugated bile salts, incorporation and assimilation of cholesterol in the cell membrane of the probiotics, intestinal conversion of cholesterol in coprostanol, and inhibition of the expression of the intestinal cholesterol transporter Niemann–Pick C1 like 1 (NPC1L1) in the enterocytes. The potential mechanisms responsible for the hypocholesterolaemic effect of probiotic yeasts include: deconjugation of bile salts; co-precipitation of intestinal cholesterol with the deconjugated bile salts; incorporation and assimilation of cholesterol in the cell membrane; and inhibition of hepatic cholesterol synthesis. The regular consumption of probiotic bacteria and yeast, as a non-pharmaceutical approach to help manage cardiovascular risk, holds promise, according to the beneficial hypocholesterolaemic effects described herein. However, the hypocholesterolaemic effects vary according to the strains used, the physiological state of the host, and the type of diet to which the probiotics are added. Further studies are necessary to fill the gaps with regard to the knowledge related to this topic.
Từ khóa
Tài liệu tham khảo
Kullisaar, 2011, An antioxidant probiotic reduces postprandial lipemia and oxidative stress, Central European Journal of Biology, 6, 32
El-Arab, 2009, Effect of yeast and botanical β-glucan on serum lipid profile and cecum probiotic bacteria using rats fed cholesterol diet, Polish Journal of Food and Nutrition Sciences, 59, 169
Tok, 2010, Cholesterol removal by some lactic acid bacteria that can be used as probiotic, Microbiology and Immunology, 54, 257
Tang, 2014, Inhibition of atherosclerotic plaque formation in ApoE-deficient mice by dietary supplementation with Lactobacillus casei, Functional Foods in Health and Disease, 4, 147, 10.31989/ffhd.v4i4.19
Klaver, 1993, The assumed assimilation of cholesterol by lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity, Applied and Environmental Microbiology, 59, 1120, 10.1128/AEM.59.4.1120-1124.1993
Wolever, 1995, Propionate inhibits incorporation of colonic [1,2-13C]acetate into plasma lipids in humans, American Journal of Clinical Nutrition, 61, 1241, 10.1093/ajcn/61.6.1241
Mann, 1974, Studies of a surfactant and cholesteremia in the Maasai, American Journal of Clinical Nutrition, 27, 464, 10.1093/ajcn/27.5.464
Mohamadshahi, 2014, Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: a randomized controlled clinical trial, Journal of Research in Medical Sciences, 19, 531
Park, 2007, Effect of dietary inclusion of Lactobacillus acidophilus ATCC 43121 on cholesterol metabolism in rats, Journal of Microbiology and Biotechnology, 17, 655
Madani, 2013, How much in vitro cholesterol reducing activity of lactobacilli predicts their in vivo cholesterol function?, International Journal of Preventive Medicine, 4, 404
Sirilun, 2010, Characterisation of non human origin probiotic Lactobacillus plantarum with cholesterol-lowering property, African Journal of Microbiology Research, 4, 994
Aloğlu, 2015, Investigation of a probiotic yeast as a cholesterol lowering agent on rats fed on a high cholesterol enriched diet, KafKas Universitesi veteriner faKUltesi Dergisi, 21, 685
Henningsson, 2001, Short-chain fatty acid formation at fermentation of indigestible carbohydrates, Scandinavian Journal of Nutrition, 45, 165
Fava, 2006, The gut microbiota and lipid metabolism: implications for human health and coronary heart disease, Current Medicinal Chemistry, 13, 3005, 10.2174/092986706778521814
2001, Probiotics in Food. Health and Nutritional Properties and Guidelines for Evaluation
Waszkiewicz-Robak B (2013) Spent brewer’s yeast and β-glucans isolated from them as diet components modifying blood lipid metabolism disturbed by an atherogenic diet. In Lipid Metabolism, chapter 12 [R Valenzuela Baez, editor]. InTech. http://www.intechopen.com/books/lipid-metabolism/spent-brewer-s-yeast-and-beta-glucans-isolated-from-them-as-diet-components-modifying-blood-lipid-me.
Liu, 2012, Effect and mechanism of cholesterol-lowering by Kluyveromyces from Tibetan Kefir, Advanced Materials Research, 343, 1290
World Health Organization (2011) Cardiovascular Disease. Fact sheet no. 317. Geneva, Switzerland: WHO. http://www.who.int/mediacentre/factsheets/fs317/en/ (accessed January 2015).